| Schedule of Share-based Compensation Expense Recognized in the Period |
The following table presents the share-based compensation expense recognized in the periods presented: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2023 | | 2022 | | 2023 | | 2022 | | Restricted stock units | $ | 25,179 | | | $ | 15,078 | | | $ | 49,970 | | | $ | 30,423 | | | Stock options | 5,309 | | | 6,160 | | | 12,793 | | | 13,818 | | | Executive Chairman Long-Term Performance Award | 13,267 | | | 13,267 | | | 26,388 | | | 26,388 | | | Employee Stock Purchase Plan | 410 | | | 643 | | | 1,013 | | | 1,524 | | | | | | | | | | | Total | $ | 44,165 | | | $ | 35,148 | | | $ | 90,164 | | | $ | 72,153 | |
|
| Summary of RSU Activity Under the Plans |
A summary of the Company's RSU activity under the Plans is as follows: | | | | | | | | | | | | | | | Number of Restricted Stock Units | | Weighted-average grant date fair value per share | | | Balance as of December 31, 2022 | 34,146,546 | | $ | 9.74 | | | | | Granted | 26,556,500 | | 4.45 | | | | | Vested | (6,289,563) | | 9.60 | | | | | Canceled and forfeited | (9,271,109) | | | 8.39 | | | | Balance as of June 30, 2023 | 45,142,374 | | $ | 6.92 | | | |
A summary of the Company's stock option activity under the Plans is as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Number of Options | | Weighted-Average Exercise Price per Share | | Weighted-Average Remaining Contractual Life | | Aggregate Intrinsic Value(1) | Balance as of December 31, 2022 | 36,156,445 | | | $ | 16.37 | | | 7.67 years | | $ | 29,101 | | | Granted | 6,080,148 | | | 5.35 | | | | | | | Exercised | (1,631,016) | | | 1.41 | | | | | | | Canceled and forfeited | (2,228,604) | | | 10.45 | | | | | | Balance as of June 30, 2023 | 38,376,973 | | $ | 15.61 | | | 7.75 years | | $ | 14,943 | | Exercisable as of June 30, 2023(2) | 11,157,842 | | $ | 11.17 | | | 7.39 years | | $ | 13,162 | | Vested as of June 30, 2023 | 8,267,104 | | $ | 9.39 | | | 6.26 years | | $ | 11,972 | |
(1) Intrinsic value is calculated based on the difference between the exercise price of in-the-money-stock options and the fair value of the common stock as of the respective balance sheet dates. (2) The 2011 Plan allows for early exercise of stock options. Accordingly, options granted under this plan are included as exercisable stock options regardless of vesting status. The Executive Chairman Long-Term Performance Award is divided into seven equal tranches which vest upon the achievement of the following Company stock price hurdles: | | | | | | | | | | | | | | | | Tranche | | Company Stock Price Hurdle | | Number of Options Eligible to Vest | | 1 | | $67.50 | | 2,826,884 | | 2 | | $78.98 | | 2,826,884 | | 3 | | $92.40 | | 2,826,884 | | 4 | | $108.11 | | 2,826,884 | | 5 | | $126.49 | | 2,826,884 | | 6 | | $147.99 | | 2,826,884 | | 7 | | $173.15 | | 2,826,884 | | Total | | | | 19,788,188 |
|
| Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions |
The fair value of stock options granted was estimated using the Black-Scholes option pricing model and the following weighted average assumptions: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2023 (1) | | 2022 | | 2023 | | 2022 | | Dividend yield | —% | | 0.0% | | 0.0% | | 0.0% | | Expected volatility | —% | | 61.90% | | 70.78% | | 59.37% | | Expected term (in years) | — | | 6.08 | | 6.04 | | 6.08 | | Risk-free interest rate | —% | | 2.81% | | 3.78% | | 2.18% |
(1) The Company did not grant any stock options during the three months ended June 30, 2023.
|